MedPath

Brief use of the Unmind digital mental health platform to help tackle depressive symptoms

Not Applicable
Completed
Conditions
ow mood and depressive symptoms
Mental and Behavioural Disorders
Registration Number
ISRCTN13067492
Lead Sponsor
nmind Ltd
Brief Summary

2023 Results article in https://doi.org/10.2196/41590 (added 19/06/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
405
Inclusion Criteria

1. Aged 18+ years
2. Currently living in the UK
3. Fluent in English
4. Currently in full- or part-time employment
5. Internet access (desktop or mobile device)
6. Active account on the Prolific study recruitment website (https://www.prolific.co/)
7. Currently experiencing subthreshold or mild to moderate low mood and depressive symptoms according to the Patient Health Questionnaire 8 item version (PHQ-8; Kroenke et al., 2009), with a score between 5 and 14 at baseline
8. A self-reported interest in using a brief digital intervention designed to help tackle low mood and depressive symptoms
9. Willingness to download the Unmind app or engage with the platform via a desktop device and create an account using a personal email address.
10. Willingness to be randomised

Exclusion Criteria

1. Self reported diagnosis of bipolar disorder, schizophrenia or other psychotic spectrum disorder, alcohol or substance use disorder, or neurocognitive disorder
2. Undergoing psychological therapy for low mood or depression with a health professional at screening
3. Previous use of the Unmind platform
4. Current or previous participation in another Unmind study
5. Participants will also be informed that they should not take part in this study should they be unwilling to commit to participation in the study period (3 weeks) and follow up (4 weeks)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath